Reproductive Techniques, Assisted Clinical Trial
Official title:
Early Follicular Phase vs Lutheal Phase Ovarian Stimulation in Bologna Criteria IVF/ICSI Cycles: A Randomized Comparative Single Center Trial. LUTEAL Trial
Exploratory, prospective, randomized, comparative, open trial with control group treated to assess the efficacy of follicular phase ovarian stimulation compared to lutheal phase ovarian stimulation in women with Bologna criteria for poor ovarian response.
Two arms is established, the study group that will start ovarian stimulation in the luteal
phase and the control group that will start ovarian stimulation in the follicular phase.
The randomization will be made in the 2-3 day of the menstrual cycle, according to a list of
random allocation of treatments. After check that there is no contraindication to start the
stimulation, the patients will be assigned to the treatment group.
The patients in the control group (follicular phase group) will start stimulation with two
vials of 150 IU recombinant FSH + 75 IU recombinant LH (Pergoveris® 150/75). The patients in
the study group (luteal phase group) will perform daily urine LH test from day 7th of the
cycle and will start the administration of 150 IU recombinant FSH + 75 IU recombinant LH
(Pergoveris® 150/75) at two vials daily from the 4th day of the LH positive test.
Antagonist cetrorelix acetate (Cetrotide® ) administration will start when the largest
follicle shall be equal or greater than 14 mm. From this moment controls every 24-72 hours
with foliculometría by ultrasound and blood hormone analysis with determination of estradiol
and progesterone. For the final oocyte maturation 2 vials daily of 0.2 mg triptorelin acetate
(Decapeptyl®) is administered. Oocyte collection will be made by transvaginal
ultrasound-guided puncture according to IB protocol
The dosages and protocols used will be the usual for patients with diagnostic of poor ovarian
response.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05442125 -
First Live Birth Rate With eSET After Preimplantation Methylome Screening (PIMS) Versus Conventional In-vitro Fertilization
|
N/A | |
| Withdrawn |
NCT00767611 -
Molecular Markers of Human Sperm Function
|
N/A | |
| Completed |
NCT04549649 -
The Effect of Dual Trigger for Final Oocyte Maturation on IVF/ICSI Outcomes in Patients With Suboptimal Ovarian Response
|
N/A | |
| Completed |
NCT02457481 -
An Alternative Culture Medium to Better Support Preimplantation Embryo Development in Vitro
|
N/A | |
| Completed |
NCT02567552 -
Clinical Trial Comparing Endometrial Transformation With Subcutaneous Progesterone Versus Intramuscular Progesterone
|
Phase 4 | |
| Completed |
NCT00518141 -
Use of Acetyl Salicylic Acid and Terbutalin in Assisted Reproductive Techniques (ART)
|
N/A | |
| Terminated |
NCT01071200 -
Study to Evaluate if the Addition of r-hLH (Luveris®) to FSH From Day 8 of Ovarian Stimulation is Able to Decrease Total FSH Dose and to Improve Cycle Outcome in Infertile Women Undergoing ART, Who Required High FSH Dose in a Previous Cycle
|
Phase 3 | |
| Recruiting |
NCT02516462 -
In Vitro Maturation of Human Eggs
|
N/A | |
| Recruiting |
NCT05473039 -
Effect of a Multivitamin Supplement With Probiotic (Seidivid Ferty4®) on Oocyte Retrieval and Quality
|
N/A | |
| Recruiting |
NCT04124913 -
Oral Dydrogesterone vs. Micronized Vaginal Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer Cycles
|
Phase 4 | |
| Completed |
NCT02381821 -
Endometrial Volume and Sub-endometrial Vascularity as Predictors of In-vitro Fertilization Success
|
N/A | |
| Recruiting |
NCT02625519 -
Efficacy of Urinary Vs Recombinant FSH in Oocyte Donors Based on Receptor N680S FSH Gene Polymorphism (Genodon Trial)
|
Phase 4 | |
| Completed |
NCT04458454 -
"Study of the Effects of Serum and Follicular Fluid Relaxin Levels on Ovarian Function in IVF Cycles"
|
||
| Active, not recruiting |
NCT03901170 -
Does Letrozole Improve Pregnancy Outcome in Fresh Embryo Transfer IVF/ICSI Cycle?
|
Phase 4 |